Teleflex Incorporated ($TFX) Stock Forecast: Up 7.9% Today

What is Teleflex Incorporated?

Teleflex Incorporated (NYSE: TFX) operates in the medical devices and technologies sector, aiming to improve healthcare solutions. The stock showed an upward trend in trading today.

Why is Teleflex Incorporated going up?

TFX stock is up 7.9% on May 7, 2026 19:43

• Strong Q1 2026 results were announced by Teleflex, surpassing earnings and revenue forecasts despite challenges from tariffs and logistics costs.
• Investor confidence was boosted by the company's strategic changes, such as planned divestitures and a share buyback initiative, leading to a rise in the stock price.
• The market responded positively to Teleflex's focus on research and development, especially for its Freesolve drug-eluting scaffold technology, alongside optimistic future projections.
• Jason Weidman's appointment as President and CEO, effective June 8, 2026, also contributed to enhanced investor confidence in the company's leadership and strategic plans.

TFX Price Chart

TFX Technical Analysis

TFX News

Teleflex Incorporated 2026 Q1 - Results - Earnings Call Presentation (NYSE:TFX) 2026-05-07

Teleflex Incorporated has published its Q1 2026 earnings call presentation. The article, written by SA Transcripts, highlights the company's financial results for the quarter. This publication provides investors with insights into Teleflex's performance.

https://seekingalpha.com/article/4900372-teleflex-incorporated-2026-q1-results-earnings-call-presentation

Earnings call transcript: Teleflex Q1 2026 beats earnings expectations, stock rises

Teleflex reported strong Q1 2026 results, exceeding earnings and revenue expectations with an adjusted EPS of $1.39 and revenue of $548.3 million. Despite facing margin pressures from tariffs and logistics costs, the company's strategic transformation, including planned divestitures and a share repurchase program, remains on track. Teleflex is also investing heavily in R&D, particularly for its Freesolve drug-eluting scaffold technology, with optimistic future guidance for 2027 and beyond.

https://www.investing.com/news/transcripts/earnings-call-transcript-teleflex-q1-2026-beats-earnings-expectations-stock-rises-93CH-4667977

Teleflex (NYSE: TFX) Q1 2026 revenue jumps 32% as EPS turns negative

Teleflex reported Q1 2026 revenue of $548.3 million, a 32.3% year-over-year increase, with GAAP diluted EPS turning negative at $(0.11) while adjusted diluted EPS was $1.39. The company maintained its full-year 2026 financial outlook, including revenue growth and adjusted EPS guidance, and expects its Strategic Divestitures to close in the second half of 2026, with proceeds earmarked for share repurchases and debt reduction. Jason Weidman has been appointed President and CEO, effective June 8, 2026.

https://www.stocktitan.net/sec-filings/TFX/8-k-teleflex-inc-reports-material-event-b967cd25ede8.html

Teleflex: Q1 Earnings Snapshot

Teleflex Inc. (TFX) reported a first-quarter loss of $8.2 million, or 18 cents per share, which was better than Wall Street's expectations. The company's adjusted earnings per share were $1.39, surpassing the average analyst estimate of $1.21. Teleflex also exceeded revenue forecasts, posting $548.3 million for the period and projecting full-year revenue between $2.28 billion and $2.3 billion.

https://www.king5.com/article/syndication/associatedpress/teleflex-q1-earnings-snapshot/616-90299d20-2cc4-4f96-90f4-cd2baac5300b

Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

Teleflex Incorporated announced its financial results for the first quarter ended March 31, 2026, reporting revenue from continuing operations of $548.3 million, a 32.3% increase compared to the prior year. The company maintained its full-year 2026 guidance, expecting GAAP revenue growth of 14.40% to 15.40% and adjusted diluted EPS from continuing operations of $6.25 to $6.55. Teleflex also highlighted its strategic divestitures set to close in the second half of 2026, aiming to return capital to shareholders and reduce debt.

https://www.businesswire.com/news/home/20260507377859/en/Teleflex-Reports-First-Quarter-Financial-Results-and-Full-Year-2026-Outlook

Trending Today

Advance Auto Parts Inc W/I ($AAP) Stock Forecast: Down 5.1% Today

NRG Energy Inc. ($NRG) Stock Forecast: Down 5.0% Today

Ubiquiti ($UI) Stock Forecast: Down 5.2% Today

Franco-Nevada Corp. ($FNV) Stock Forecast: Down 5.2% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Up 11.1% Today

Ford Motor Company ($F) Stock Forecast: Down 7.1% Today

ServiceNow Inc. ($NOW) Stock Forecast: Up 5.0% Today

Kornit Digital Ltd. ($KRNT) Stock Forecast: Down 5.4% Today

Aptiv PLC ($APTV) Stock Forecast: Down 5.0% Today

Teradyne, Inc. ($TER) Stock Forecast: Down 5.6% Today

Teleflex Incorporated Price History

07.04.2026 - TFX Stock was up 10.9%

• TFX stock outperformed its competitors and the broader market, with shares rising by 2.10% to $123.23, marking a second consecutive day of gains.
• Institutional investors like Strs Ohio and PFA Pension Forsikringsaktieselskab significantly increased their holdings in TFX, showing confidence in the company's long-term prospects despite a weak quarter reported earlier.
• The upcoming first-quarter earnings call scheduled for May 7 may have generated positive sentiment among investors, anticipating potential positive financial results and operational updates.
• The recent bullish movement in TFX could also be attributed to the overall favorable trading session in the market, as indicated by the increases in the S&P 500 Index and Dow Jones Industrial Average.

07.04.2026 - TFX Stock was up 7.9%

• Strong Q1 2026 results were announced by Teleflex, surpassing earnings and revenue forecasts despite challenges from tariffs and logistics costs.
• Investor confidence was boosted by the company's strategic changes, such as planned divestitures and a share buyback initiative, leading to a rise in the stock price.
• The market responded positively to Teleflex's focus on research and development, especially for its Freesolve drug-eluting scaffold technology, alongside optimistic future projections.
• Jason Weidman's appointment as President and CEO, effective June 8, 2026, also contributed to enhanced investor confidence in the company's leadership and strategic plans.

22.03.2026 - TFX Stock was up 5.5%

• An acquisition of shares in Teleflex by Ruffer LLP has taken place despite missed earnings and revenue estimates, possibly indicating a positive long-term outlook on the company.
• The surge in Teleflex stock value following a joint bid from private equity firms hints at market optimism and the potential for strategic restructuring ahead.
• Despite trailing behind competitors and facing a recent share price decline, the interest from private equity firms and recent board changes appear to be fueling bullish sentiment in the market.
• The potential takeover bid by CVC Capital Partners and GTCR aligns with the industry trend of consolidation in medical technology, further supporting the positive market sentiment towards Teleflex.

16.03.2026 - TFX Stock was up 3.6%

• TFX stock experienced a strong bullish movement, rising 1.65% to $125.21, outperforming the broader market indices.
• The bullish trend can be attributed to a price target increase on TFX to $135 from $125, indicating confidence in the company's performance and growth prospects.
• Despite missing Q4 earnings expectations and reporting a revenue decline, TFX's focus on specialized products, global footprint, and commitment to innovation have positioned it as a defensive play in the healthcare sector, appealing to investors seeking reliable growth.
• The positive performance of TFX amidst a general uplift in the stock market reflects investor confidence in the company's market leadership and potential for steady shareholder returns.

26.01.2026 - TFX Stock was up 10.1%

• The recent upward trend in TFX may be linked to expectations of favorable Q4 earnings, with analysts forecasting a 15.9% increase in revenue compared to the previous year.
• Despite being tagged as overvalued by a DCF analysis, the company's lower valuation in relation to its industry counterparts based on the Price/Sales ratio could be drawing investor interest.
• Although brokerages have given TFX an average "Hold" rating, the optimism surrounding potential earnings and the strong performance of industry peers could be bolstering confidence among investors.
• The recent announcement of new leadership at MassMEDIC, a notable development in the medical device sector, is not directly tied to TFX's recent positive movement.

30.03.2026 - TFX Stock was down 8.2%

• Teleflex Inc. stock fell by 1.64% today, underperforming compared to its competitors and closing at $133.30.
• The bearish movement could be attributed to concerns raised by activist hedge fund Irenic Capital Management regarding the company's underperformance since the 2017 acquisition of Vascular Solutions and their push for strategic alternatives, including a potential sale.
• Despite its stable market position and growth potential in the healthcare sector, investors may be cautious due to the company's recent stock underperformance and the uncertainty surrounding potential buyout offers.
• Monitoring Teleflex's earnings, product launches, and responses to activist investor pressure will be crucial in assessing its future performance and investment attractiveness.

30.03.2026 - TFX Stock was down 7.7%

• The appointment of Jason Weidman as the new President and CEO of Teleflex may have initially sparked investor interest and optimism in the company's future growth strategy.
• However, the significant stake reported by Vanguard Portfolio Management could have led to concerns among investors about potential changes in the company's direction or governance.
• The focus on repositioning the business around core markets and planned divestitures might have raised uncertainties about short-term financial performance, contributing to the bearish movement in TFX stock.
• The announcement of a $1 billion share buyback and $800 million debt paydown could have signaled to investors a shift towards financial restructuring, impacting the stock's performance negatively in the short term.

27.02.2026 - TFX Stock was up 5.1%

• Despite industry challenges and regulatory scrutiny, Teleflex Inc. (TFX) experienced a significant bullish movement today.
• Investor confidence in the company's innovation, global presence, and cost management likely supported this positive trend.
• Optimism about potential recovery in hospital spending and strategic plans, such as a potential split, may have contributed to the market optimism.
• Despite trailing behind competitors, consecutive days of stock gains indicate growing positive sentiment and long-term potential interest from investors.

27.02.2026 - TFX Stock was up 5.1%

• Recent investor interest in Teleflex Inc. (TFX) has been driven by encouragement from activist investor, Irenic Capital Management, for the company to explore acquisition offers, potentially boosting optimism regarding its strategic decisions.
• Despite challenges such as constrained hospital budgets and FDA product reviews, Teleflex's commitment to innovation and cost efficiencies has resonated positively with investors, contributing to its strong stock performance.
• TFX stock has seen consecutive gains while the broader market faced challenges, signaling investor confidence in the company's ability to overcome industry obstacles and seize growth prospects.
• Although TFX stock has shown daily advances, its relative underperformance compared to peers suggests lingering investor concerns about competitive positioning and market dynamics that warrant close observation.

14.03.2026 - TFX Stock was up 5.1%

• Teleflex stock saw a 4.05% increase today, surpassing its competitors and the overall market.
• The surge in stock value is believed to be linked to an upgrade by Bank of America from 'underperform' to 'neutral', setting a price target of $135, indicating a more favorable outlook for the company.
• Recent governance changes, adjustments to the company's portfolio, and improved earnings visibility resulting from buybacks and debt reduction have all played a role in the stock's upward movement.
• Despite falling short of Q4 earnings predictions and a decrease in revenue, Teleflex's strategic actions and positive analyst feedback have boosted investor confidence, leading to the strong performance witnessed today.

21.03.2026 - TFX Stock was down 5.1%

• A reduction in Teleflex's stake by Cwm LLC following a significant miss in quarterly earnings and revenue expectations likely impacted the bearish movement.
• The acquisition of Teleflex shares by Waterfront Wealth Inc. possibly brought temporary relief, but the general sentiment remains mixed, with analysts giving an average "Hold" rating.
• Teleflex's strategic initiatives, like nominating a new director, planning share buybacks, and implementing board changes, suggest efforts to address undervaluation, yet market response appears cautious.
• The Google Discover Core Update offering personalized insights on Teleflex to investors may have heightened market volatility as investors adjust to new ways of accessing financial information, potentially fueling the negative sentiment surrounding the stock.

17.03.2026 - TFX Stock was up 5.6%

• Despite recent earnings missing analyst expectations, reporting lower EPS and revenue decline, the company's focus on specialized products and innovation pipeline positions it as a defensive play in the market.
• The global vascular closure devices market is expected to grow steadily, with Teleflex being a key player in this sector, driving potential growth for the company.
• Teleflex's stock outperformed competitors and the broader market indices, showing resilience and investor confidence in the company.
• Analysts have a consensus "Hold" rating on Teleflex with a target price increase by RBC Capital, indicating positive sentiment towards the company's future prospects. The bullish movement in Teleflex's stock could be attributed to the positive market sentiment, potential growth in the vascular closure devices market, and investor confidence in the company's long-term strategy.